相关实验视频
Updated: Apr 29, 2026

10:40
CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis
Published on: April 25, 2022
2.8K
可穿戴的纳米补丁平台用于实时miRNA传感和编辑:下一代癌症管理的愿景
K P Ameya1, Kehinde Ross2, Durairaj Sekar3
1RNA Biology Lab, Saveetha Dental College and Hospital, Saveetha Institute of Medical and Technical Science (SIMATS), Saveetha University, Chennai, 600077, India.
Medical oncology (Northwood, London, England)
|November 17, 2025
概括
个性化癌症治疗正在推进,微RNAs (miRNAs) 作为生物标志物和治疗点. 可穿戴生物传感器和miRNA编辑补丁可以实时进行适应性治疗,以改善患者的治疗结果.
科学领域:
- 在瘤学瘤学.
- 生物技术是生物技术.
- 分子生物学分子生物学
背景情况:
- 微RNAs (miRNAs) 是癌症生物学中的关键调节者,其改变的表达作为早期检测和治疗点的生物标志物.
- 可穿戴的生物传感技术,包括智能带和微针阵列,可以在间歇性液体中对miRNA进行最小侵入性监测.
研究的目的:
- 审查miRNAs在癌症中的作用.
- 讨论用于癌症治疗的可穿戴生物传感和基因编辑的技术进步.
- 为了确定下一代个性化癌症治疗平台的翻译挑战.
主要方法:
- 关于癌症中miRNA功能的科学文献的综述.
- 对用于生物标志物检测的可穿戴生物传感技术的最新发展进行分析.
- 探索用于治疗应用的新兴miRNA编辑贴片技术.
主要成果:
- miRNAs对于癌症的调节,检测和治疗至关重要.
- 可穿戴生物传感器提供实时,最少侵入性的miRNA监测.
- 可穿戴的miRNA编辑贴片代表了适应性局部癌症治疗的新方法.
结论:
- 可穿戴技术和miRNA编辑补丁正在为动态,个性化的癌症治疗铺平道路.
- 解决诸如生物相容性,向性交付和监管批准等挑战对于临床翻译至关重要.
- 这种综合方法有望为未来的适应性,实时癌症治疗提供针对个体患者的量身定制治疗.
相关概念视频
MicroRNAs
21.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.0K
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K

